New Cancer Drug Cocktail Shrinks Tumors in Majority of Trial Participants

pancreatic cancer drug daraxonrasib

Pancreatic cancer drug daraxonrasib A promising new cancer treatment combination is offering fresh hope for patients battling advanced pancreatic cancer after early clinical trial results showed significant tumor reduction in most participants. Researchers found that combining an experimental oral medication with two standard chemotherapy drugs helped shrink tumors or stop cancer growth in the majority … Read more